Ultomiris® (ravulizumab-cwvz)
| Full Name | Ultomiris® (ravulizumab-cwvz) |
| Drug | Ultomiris |
| Manufacturer | Alexion (purchased by AZ) |
| Route of Administration | Intravenous |
| Site of Care | Home or Healthcare Facility |
| Approved Indication | The treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) |
| Disease | Paroxysmal Nocturnal Hemoglobinuria (PNH); Atypical Hemolytic Uremic Syndrome (aHUS) |
| Therapeutic Area | Hematology |
| Enrollment Form Link | Enrollment Form |
| Phone Number | N/A |
| Fax Number | N/A |
| Product Website | ultomirishcp.com/nmosd |